endometriosis uk trading limited
endometriosis uk trading limited Company Information
Company Number
05836007
Next Accounts
Dec 2024
Industry
Other human health activities
Shareholders
endometriosis uk
Group Structure
View All
Contact
Registered Address
10 - 18 union street, union street, london, SE1 1SZ
Website
www.endometriosis-uk.orgendometriosis uk trading limited Estimated Valuation
Pomanda estimates the enterprise value of ENDOMETRIOSIS UK TRADING LIMITED at £7 based on a Turnover of £7 and 1.06x industry multiple (adjusted for size and gross margin).
endometriosis uk trading limited Estimated Valuation
Pomanda estimates the enterprise value of ENDOMETRIOSIS UK TRADING LIMITED at £0 based on an EBITDA of £-8.1k and a 8.13x industry multiple (adjusted for size and gross margin).
endometriosis uk trading limited Estimated Valuation
Pomanda estimates the enterprise value of ENDOMETRIOSIS UK TRADING LIMITED at £7.1k based on Net Assets of £2.9k and 2.46x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Endometriosis Uk Trading Limited Overview
Endometriosis Uk Trading Limited is a live company located in london, SE1 1SZ with a Companies House number of 05836007. It operates in the other human health activities sector, SIC Code 86900. Founded in June 2006, it's largest shareholder is endometriosis uk with a 100% stake. Endometriosis Uk Trading Limited is a established, micro sized company, Pomanda has estimated its turnover at £7 with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Endometriosis Uk Trading Limited Health Check
Pomanda's financial health check has awarded Endometriosis Uk Trading Limited a 1 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 5 areas for improvement. Company Health Check FAQs
1 Strong
1 Regular
5 Weak
Size
annual sales of £7, make it smaller than the average company (£716.8k)
£7 - Endometriosis Uk Trading Limited
£716.8k - Industry AVG
Growth
3 year (CAGR) sales growth of -96%, show it is growing at a slower rate (5.4%)
-96% - Endometriosis Uk Trading Limited
5.4% - Industry AVG
Production
with a gross margin of 100%, this company has a lower cost of product (36.2%)
100% - Endometriosis Uk Trading Limited
36.2% - Industry AVG
Profitability
an operating margin of -116228.6% make it less profitable than the average company (6.3%)
-116228.6% - Endometriosis Uk Trading Limited
6.3% - Industry AVG
Employees
with 1 employees, this is below the industry average (19)
1 - Endometriosis Uk Trading Limited
19 - Industry AVG
Pay Structure
on an average salary of £24.6k, the company has an equivalent pay structure (£24.6k)
- Endometriosis Uk Trading Limited
£24.6k - Industry AVG
Efficiency
resulting in sales per employee of £7, this is less efficient (£43.6k)
£7 - Endometriosis Uk Trading Limited
£43.6k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Endometriosis Uk Trading Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Endometriosis Uk Trading Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Endometriosis Uk Trading Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Endometriosis Uk Trading Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Endometriosis Uk Trading Limited
- - Industry AVG
ENDOMETRIOSIS UK TRADING LIMITED financials
Endometriosis Uk Trading Limited's latest turnover from March 2023 is £7 and the company has net assets of £2.9 thousand. According to their latest financial statements, Endometriosis Uk Trading Limited has 1 employee and maintains cash reserves of £1.5 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 7 | 11,849 | 12,818 | 100,000 | 10,000 | 0 | ||||||||
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | |||||||||
| Cost Of Sales | 0 | 0 | 0 | 0 | 0 | |||||||||
| Gross Profit | 7 | 11,849 | 12,818 | 100,000 | 0 | |||||||||
| Admin Expenses | 8,143 | 896 | 2,530 | 341 | 0 | |||||||||
| Operating Profit | -8,136 | 10,953 | 10,288 | 99,659 | 99,311 | 0 | ||||||||
| Interest Payable | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||
| Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||
| Pre-Tax Profit | -8,136 | 10,953 | 10,288 | 99,659 | 99,311 | 0 | ||||||||
| Tax | 0 | 0 | 0 | -249 | 0 | 0 | ||||||||
| Profit After Tax | -8,136 | 10,953 | 10,288 | 99,410 | 99,311 | 0 | ||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||
| Retained Profit | -8,136 | 10,953 | 10,288 | 99,410 | 99,311 | 0 | ||||||||
| Employee Costs | 0 | |||||||||||||
| Number Of Employees | 1 | 1 | 1 | 1 | ||||||||||
| EBITDA* | -8,136 | 10,953 | 10,288 | 99,659 | 99,311 | 0 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 2,080 | 8,534 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 1,383 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 1,492 | 1,088 | 9,786 | 103,007 | 120,986 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 2,875 | 3,168 | 18,320 | 103,007 | 120,986 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total assets | 2,875 | 3,168 | 18,320 | 103,007 | 120,986 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 7,921 | 4,498 | 2,036 | 1,736 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 2,812 | 249 | 19,938 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 0 | 7,921 | 7,310 | 2,285 | 21,674 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 0 | 7,921 | 7,310 | 2,285 | 21,674 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| net assets | 2,875 | -4,753 | 11,010 | 100,722 | 99,312 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total shareholders funds | 2,875 | -4,753 | 11,010 | 100,722 | 99,312 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | -8,136 | 10,953 | 10,288 | 99,659 | 99,311 | 0 | ||||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||
| Tax | 0 | 0 | 0 | -249 | 0 | 0 | ||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -697 | -6,454 | 8,534 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | -2,812 | 2,563 | -19,689 | 19,938 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | -7,439 | 14,595 | 4,317 | 79,721 | 119,249 | 0 | ||||||||
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | -7,921 | 3,423 | 2,462 | 300 | 1,736 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||
| cash flow from financing | 7,843 | -23,293 | -97,538 | -97,700 | 1,736 | 1 | ||||||||
| cash and cash equivalents | ||||||||||||||
| cash | 404 | -8,698 | -93,221 | -17,979 | 120,985 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 404 | -8,698 | -93,221 | -17,979 | 120,985 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
endometriosis uk trading limited Credit Report and Business Information
Endometriosis Uk Trading Limited Competitor Analysis
Perform a competitor analysis for endometriosis uk trading limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in SE1 area or any other competitors across 12 key performance metrics.
endometriosis uk trading limited Ownership
ENDOMETRIOSIS UK TRADING LIMITED group structure
Endometriosis Uk Trading Limited has no subsidiary companies.
endometriosis uk trading limited directors
Endometriosis Uk Trading Limited currently has 3 directors. The longest serving directors include Ms Frances Campbell (Jul 2021) and Ms Tracey Hammonds (Jul 2021).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Ms Frances Campbell | United Kingdom | 69 years | Jul 2021 | - | Director |
| Ms Tracey Hammonds | England | 45 years | Jul 2021 | - | Director |
| Ms Helen McLaughlin | England | 39 years | Jan 2024 | - | Director |
P&L
March 2023turnover
7
-100%
operating profit
-8.1k
-174%
gross margin
100%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
2.9k
-1.6%
total assets
2.9k
-0.09%
cash
1.5k
+0.37%
net assets
Total assets minus all liabilities
endometriosis uk trading limited company details
company number
05836007
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
June 2006
age
18
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
March 2023
previous names
endometriosis uk limited (January 2009)
accountant
SAYER VINCENT
auditor
-
address
10 - 18 union street, union street, london, SE1 1SZ
Bank
CAF BANK LIMITED
Legal Advisor
BATES WELLS & BRAITHWAITE
endometriosis uk trading limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to endometriosis uk trading limited.
endometriosis uk trading limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ENDOMETRIOSIS UK TRADING LIMITED. This can take several minutes, an email will notify you when this has completed.
endometriosis uk trading limited Companies House Filings - See Documents
| date | description | view/download |
|---|
